Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2021

01-02-2021 | Correction

Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations

Authors: Matthew S. Katz, Linda McCall, Karla Ballman, Reshma Jagsi, Bruce G. Haffty, Armando E. Giuliano

Published in: Breast Cancer Research and Treatment | Issue 3/2021

Login to get access

Excerpt

Unfortunately, the original version of the article was published with incorrect NCT number (NCT00003854) in abstract section”. …
Metadata
Title
Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations
Authors
Matthew S. Katz
Linda McCall
Karla Ballman
Reshma Jagsi
Bruce G. Haffty
Armando E. Giuliano
Publication date
01-02-2021
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2021
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05980-0

Other articles of this Issue 3/2021

Breast Cancer Research and Treatment 3/2021 Go to the issue

Preclinical study

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

Clinical trial

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial

Epidemiology

Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features

Review

Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?

Review

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management

Epidemiology

Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits